An efficient and scalable pipeline for epitope tagging in mammalian stem cells using Cas9 ribonucleoprotein
Pooran Singh Dewari,
Benjamin Southgate,
Katrina Mccarten,
German Monogarov,
Eoghan O'Duibhir,
Niall Quinn,
Ashley Tyrer,
Marie-Christin Leitner,
Colin Plumb,
Maria Kalantzaki,
Carla Blin,
Rebecca Finch,
Raul Bardini Bressan,
Gillian Morrison,
Ashley M Jacobi,
Mark A Behlke,
Alex von Kriegsheim,
Simon Tomlinson,
Jeroen Krijgsveld,
Steven M Pollard
Affiliations
Pooran Singh Dewari
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Benjamin Southgate
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Katrina Mccarten
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
German Monogarov
German Cancer Research Center, University of Heidelberg, Heidelberg, Germany
Eoghan O'Duibhir
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Niall Quinn
Institute of Genetics and Molecular Medicine, Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom
Ashley Tyrer
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Marie-Christin Leitner
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Colin Plumb
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Maria Kalantzaki
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Carla Blin
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Rebecca Finch
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Gillian Morrison
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Ashley M Jacobi
Integrated DNA Technologies, Inc., Coralville, United States
Mark A Behlke
Integrated DNA Technologies, Inc., Coralville, United States
Alex von Kriegsheim
Institute of Genetics and Molecular Medicine, Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom
Simon Tomlinson
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
Jeroen Krijgsveld
German Cancer Research Center, University of Heidelberg, Heidelberg, Germany
Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom; MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
CRISPR/Cas9 can be used for precise genetic knock-in of epitope tags into endogenous genes, simplifying experimental analysis of protein function. However, Cas9-assisted epitope tagging in primary mammalian cell cultures is often inefficient and reliant on plasmid-based selection strategies. Here, we demonstrate improved knock-in efficiencies of diverse tags (V5, 3XFLAG, Myc, HA) using co-delivery of Cas9 protein pre-complexed with two-part synthetic modified RNAs (annealed crRNA:tracrRNA) and single-stranded oligodeoxynucleotide (ssODN) repair templates. Knock-in efficiencies of ~5–30%, were achieved without selection in embryonic stem (ES) cells, neural stem (NS) cells, and brain-tumor-derived stem cells. Biallelic-tagged clonal lines were readily derived and used to define Olig2 chromatin-bound interacting partners. Using our novel web-based design tool, we established a 96-well format pipeline that enabled V5-tagging of 60 different transcription factors. This efficient, selection-free and scalable epitope tagging pipeline enables systematic surveys of protein expression levels, subcellular localization, and interactors across diverse mammalian stem cells.